Table 1

Clinical characteristics at baseline and end of study

Baseline90th weekP#
n (women/men)86 (39/47)
Age (years)58 ± 9
Height (cm)169 ± 11
Body weight (kg)85.9 ± 18.282.7 ± 17.3<0.0001
BMI (kg/m2)29.8 ± 4.528.7 ± 4.1<0.0001
HbA1c (%) [mmol/mol]7.8 ± 0.8 [62 ± 9]7.1 ± 0.7 [54 ± 8]<0.0001
LDL-cholesterol (mg/dL)111 ± 32117 ± 43NS
HDL-cholesterol (mg/dL)48 ± 1155 ± 14<0.001
Triglycerides (mg/dL)194 ± 175181 ± 89NS
eGFR (mL · min−1 · 1.73 m−2)89 ± 1984 ± 180.0003
FPG (mg/dL)169 ± 41143 ± 22<0.0001
Fat-free mass (kg)55.3 ± 12.554.4 ± 12.4<0.0001
Fat mass (kg)30.6 ± 10.228.4 ± 9.2<0.0001
TDEE (kcal/day)2,139 [693]2,192 [652]0.0037
  • Data are mean ± SD or median [IQR].

  • #Wilcoxon signed rank test.